Baird Medical Investment Holdings Limited - Asset Resilience Ratio
Baird Medical Investment Holdings Limited (BDMD) has an Asset Resilience Ratio of 0.38% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Baird Medical Investment Holdings Limite to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how Baird Medical Investment Holdings Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Baird Medical Investment Holdings Limite.
Liquid Assets Composition Over Time
This chart breaks down Baird Medical Investment Holdings Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read how much debt does Baird Medical Investment Holdings Limite carry for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $295.75K | 0.38% |
| Total Liquid Assets | $295.75K | 0.38% |
Asset Resilience Insights
- Limited Liquidity: Baird Medical Investment Holdings Limited maintains only 0.38% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Baird Medical Investment Holdings Limited Industry Peers by Asset Resilience Ratio
Compare Baird Medical Investment Holdings Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for Baird Medical Investment Holdings Limited (2019–2024)
The table below shows the annual Asset Resilience Ratio data for Baird Medical Investment Holdings Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.38% | $295.75K | $77.96 Million | +0.17pp |
| 2023-12-31 | 0.21% | $120.48K | $56.71 Million | -0.25pp |
| 2022-12-31 | 0.46% | $197.00K | $42.62 Million | -1.10pp |
| 2021-12-31 | 1.56% | $407.50K | $26.12 Million | +1.18pp |
| 2020-12-31 | 0.38% | $65.11K | $17.02 Million | +0.07pp |
| 2019-12-31 | 0.31% | $36.62K | $11.76 Million | -- |
About Baird Medical Investment Holdings Limited
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, in… Read more